TMDX
TransMedics Group, Inc. · Healthcare
Director David Weill sold $1.2M of TransMedics Group, Inc.
Sold$1,212,120
$56.00Price
21,645Shares
−62%Stake
What TMDX did after the filing
- The stock from Mon, Nov 14 close, $57.54
- +2.2%
- S&P 500, same days
- −4.2%
Measured over 30 trading days, to the Dec 28 close.
Traded Thu, Nov 10. Filed Mon, Nov 14, 2:17 PM ET, during the session. Returns use the Nov 14 close and the Dec 28 close. Not investment advice.